News
Researchers in the US have identified a protein in the brain that may reduce the spread of the toxic alpha-synuclein protein in Parkinson's.
Researchers at King's College London have investigated the properties of over 1,000 approved drugs to identify 2 with potential for Parkinson's.
The results indicate that, when given early, the molecule Anle138b may restore dopamine levels and help slow or stop Parkinson’s in its tracks.
Researchers in the US have launched a clinical trial to test a drug with the potential to slow the progression of Lewy body dementia.
Our values shape the new volunteer awards, so we take a look at some of the volunteers showcasing them.
People with bipolar disorder are almost 7 times more likely to develop Parkinson's than those without the condition, according to new research published in the journal Neurology.
The STEADY-PD clinical trial has failed to show that isradipine is an effective treatment to slow or stop progression in early Parkinson's.
Research shows that problems with recycling in brain cells in Parkinson's are overcome by the malaria drug clioquinol.
News about joint work with the Scottish Government to research exercise and impact it has on Parkinson's.
Results from a trial of spinal cord stimulation carried out in Ontario, Canada highlights its potential for improving walking in Parkinson's.